Coluracetam es un nootrópico que pertenece a la familia Racetam. Los racetams son una clase de compuestos que tienen la misma columna vertebral química (un núcleo de pirrolidona). Aunque su mecanismo exacto de acción sigue siendo desconocido, Algunos racetams parecen modular los neurotransmisores.
Coluracetam se desarrolló originalmente en 2005 as a potential treatment for Alzheimer’s disease. Later on, it was in phase 2 clinical trials for the treatment of anxiety and depression. Sin embargo, clinical research was discontinued after it failed to give conclusive results in both trials.
Dosis:5-20 mg 2-3x daily
We recommend starting at the lower end of this range and increasing gradually until you find the best dose.
Preventing and reversing cognitive decline
Reducing the symptoms of Alzheimer's disease and dementia
Improving mood and reducing symptoms of depression
Treating anxiety disorders
Helping to repair damage to the brain and eyes
Increasing choline uptake
Enhancing long-term potentiation
Formulario de Consulta ( nos pondremos en contacto con usted tan pronto como sea posible )